Scarica l'app Stockscreener
1.53
3.68%
-0.0584
Dopo l'orario di chiusura:
1.53
Precedente Chiudi:
$1.5884
Aprire:
$1.53
Volume 24 ore:
467
Relative Volume:
0.06
Capitalizzazione di mercato:
$39.68M
Reddito:
-
Utile/perdita netta:
$-10.49M
Rapporto P/E:
-3.2553
EPS:
-0.47
Flusso di cassa netto:
$-9.58M
1 W Prestazione:
-9.47%
1M Prestazione:
-21.99%
6M Prestazione:
-33.48%
1 anno Prestazione:
-29.17%
Intervallo 1D:
$1.53
$1.53
Intervallo di 1 settimana:
$1.52
$1.7299
Portata 52W:
$1.46
$3.30
Anebulo Pharmaceuticals Inc Stock (ANEB) Company Profile
Nome
Anebulo Pharmaceuticals Inc
Settore
Industria
Telefono
737 203 5270
Indirizzo
JFL CAPITAL MANAGEMENT, LAKEWAY
Confronta ANEB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| ANEB | 1.53 | 39.68M | 0 | -10.49M | -9.58M | -0.47 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Anebulo Pharmaceuticals Inc Borsa (ANEB) Ultime notizie
Anebulo Pharmaceuticals Advances Cannabis Toxicity Solutions - MSN
Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2025 Financial Results and Recent Updates - Defense World
Anebulo Pharma Secures $1.9M NIDA Grant for Cannabis Toxicity Treatment Development | ANEB Stock News - StockTitan
Anebulo Pharmaceuticals stock hits 52-week low at $1.72 - Investing.com
Anebulo Pharmaceuticals stock hits 52-week low at $1.72 By Investing.com - Investing.com UK
Exxaro Resources (OTCMKTS:EXXAY) Share Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World
Lexeo Therapeutics’ (LXEO) “Buy” Rating Reiterated at Chardan Capital - Defense World
Short Interest in Janone Inc. (NASDAQ:ALTS) Expands By 10.2% - Defense World
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.21% - MSN
Anebulo Pharmaceuticals Updates Corporate Presentation - TipRanks
Anebulo To Report Acute Cannabinoid Intoxication Trial Data In June - RTTNews
Benchmark maintains Speculative Buy on Anebulo stock By Investing.com - Investing.com Canada
Anebulo Pharmaceuticals (NASDAQ:ANEB) Earns "Speculative Buy" Rating from Benchmark - MarketBeat
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Up 27.7% in September - Defense World
Anebulo Pharmaceuticals reports Q4 EPS (5c) vs. (10c) last year - TipRanks
Anebulo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended June 30, 2024 - Marketscreener.com
Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Recent Updates - Business Wire
Njabulo Blom set to boost Kaizer Chiefs midfield - FarPost
Kirkland Advises Luminate Capital Partners on its Investment in AbsenceSoft - Legal Desire News Network
Amway marks “Amway Health Run 2024” to celebrate Nutrilite’s 90th anniversary - Nation Thailand
Market Movers Monday: KAVL, PRSO, TGL, PNPNF, NVVE Surge on Breaking Developments - openPR
'Survival instinct kicked in': Survivor of Five Points South mass shooting speaks out - Alabama's News Leader
Langley double-shooting kills one, injures another - CityNews Vancouver
Here's Why We're Watching Anebulo Pharmaceuticals' (NASDAQ:ANEB) Cash Burn Situation - Yahoo Finance
One dead, one wounded after 2 men shot in Langley - MSN
Anebulo Pharmaceuticals Secures NIH Grant for Emergency Cannabis Antidote Development - BP Journal
Indian Super League: Anwar Ali cleared to play for East Bengal, say reports - Scroll.in
Anwar Ali receives NOC from AIFFWhen will he make East Bengal debut? - myKhel
Aligos' fatty liver disease treatment meets main goal in mid-stage study - XM
AmaZulu coach Pablo Franco defends Veli Mothwa as Kaizer Chiefs game looms - IOL
Banzai International, Inc. (NASDAQ:BNZI) Sees Large Growth in Short Interest - Defense World
Global X Active Canadian Dividend ETF Common (TSE:HAL) Stock Passes Above 200 Day Moving Average of $20.01 - Defense World
Applied Therapeutics Surges on Positive FDA Update for Govorestat - BP Journal
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Sees Significant Growth in Short Interest - MarketBeat
'Very stupid': Man who helped supply gun later used in Auckland CBD shooting sentenced - New Zealand Herald
Driver arrested in Muse homicide wants assault charge dropped - Bowling Green Daily News
Josue is now a KL City legend - New Straits Times
Scilex Holding (NASDAQ:SCLX) Stock Quotes, Forecast and News Summary - Benzinga
Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Declines By 5.3% - Defense World
XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with a Precision-Medicine Approach - BP Journal
Short Interest in Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Declines By 8.3% - MarketBeat
Anebulo Pharmaceuticals, Inc. (NASDAQ:ANEB) Short Interest Update - Defense World
Anebulo Pharmaceuticals Announces New CEO - GuruFocus.com
Can Actinium Pharmaceuticals (ATNM) bounce back from the Regulatory Hurdles - BP Journal
Anebulo Pharmaceuticals (NASDAQ:ANEB) Shares Down 4% - Defense World
Telehealth Innovations (VSEE) on day when Dow loses more than 750 points - BP Journal
After-Market Stock Rise In Anebulo (ANEB) Indicates Potential Shift In Investor Sentiment - Stocks Telegraph
Is today’s surge in Dermata Therapeutics (DRMA) justified ? - BP Journal
Anebulo Pharmaceuticals receives NIDA grant for drug development By Investing.com - Investing.com Canada
Anebulo Pharmaceuticals receives NIDA grant for drug development - Investing.com
Anebulo Pharmaceuticals Awarded NIDA Grant for its Investigational IV Treatment for Acute Cannabis-Induced Toxic Effects - Winchester Herald Chronicle
Anebulo Pharmaceuticals Inc Azioni (ANEB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):